Suppression of UV-induced mutations by wild-type p53 protein in human osteosarcoma cells

Mutagenesis

Volumn 12, Issue 3, 1997, Pages 191-194

  Yamagishi, Nobuyuki ^a   Miyakoshi, Junji ^a   Yagi, Takashi ^a   Takebe, Hiraku ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PROTEIN P53;

ARTICLE; GENE MUTATION; HUMAN; HUMAN CELL; NUCLEIC ACID BASE SUBSTITUTION; OSTEOSARCOMA CELL; PLASMID; PRIORITY JOURNAL; SHUTTLE VECTOR; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION;

BASE SEQUENCE; DNA REPAIR; GENETIC VECTORS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MOLECULAR SEQUENCE DATA; MUTATION; OSTEOSARCOMA; PLASMIDS; SUPPRESSION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0030946795     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/12.3.191     Document Type: Article

References (23)

1. Di Leonardo, A., Linke, S.P., Clarkin, K. and Wahl, G.M. (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 8, 2540-2551.
2. Donehower, L.A. and Bradley, A. (1993) The tumor suppressor p53. Biochim. Biophys. Acta, 1155, 181-205.
3. Dulic, V., Kaufmann, W.K., Wilson, S.J., Tisty, T.D., Lees, E., Harper, J.W, Elledge, S.J. and Reed, S.I. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023.
4. Fieck, A., Wyborski, D.L. and Short, J.M. (1992) Modifications of the E.coli Lac represser for expression in eukaryotic cell: effects of nuclear signal sequences on protein activity and nuclear accumulation. Nucleic Acids Res., 20, 1785-1791.
5. Ford, J.M. and Hanawalt, P.C. (1995) Li-Fraumeni syndrome fibroblasts homozygous for p53 mutatios are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. USA, 92, 8876-8880.
6. Harvey, M., Sands, A.T., Weiss, R.S., Hegi, M.E., Wiseman, R.W., Pantazis, P., Giovanella, B.C., Tainsky, M.A., Bradley, A. and Donehower, L.A. (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene, 8, 2457-2467.
7. Havre, P.A., Yuan, J., Hedrick, L., Cho, K.R. and Glazer, P.M. (1995) p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res., 55, 4420-4424.
8. Ishizaki, K., Ejima, Y., Matsunaga, T., Hara, R., Sakamoto, A., Ikenaga, M., Ikawa, Y. and Aizawa, S. (1994) Increased UV-induced SCEs but normal repair of DNA damage in p53-deficient mouse cells. Int. J. Cancer, 58, 254-257.
9. Kastan, M.B., Zhan, Q., El-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B. and Fornace, A.J., Jr (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxiatelangiectasia. Cell, 71, 587-597.
10. Lane, D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
11. Lee, S., Elenbaas, B., Levine, A. and Griffith, J. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/ deletion mismatches. Cell, 81, 1013-1020.
12. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T. and Tisty, T.D. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935.
13. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
14. Lu, X. and Lane, D.P. (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: detects in chromosome instability syndorome. Cell, 75, 765-778.
15. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, J.Z., Tainsky, M.A. and Friend, S.H. (1990) Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science, 250, 1233-1238.
16. Matsuda, T., Yagi, T., Kawanishi, M., Matsui, S. and Takebe, H. (1995) Molecular analysis of mutations induced by 2-chloroacetaldehyde, the ultimate carcinogenic form of vinyl chloride, in human cells using shuttle vectors. Carcinogenesis, 16, 2389-2394.
17. Matsumura, Y., Sato, M., Nishigori, C., Zghal, M., Yagi, T., Imamura, S. and Takebe, H. (1995) High prevalence of mutations in the p53 gene in poorly differentiated squamous cell carcinomas in xerderma pigmentosum patients. J. Invest. Dermatol., 105, 399-401.
18. Smith, M.L., Chen, I.T., Zhan, Q., O'Connor, P.M. and Fornace, A.J., Jr (1995) Involvement of p53 tumor suppressor in repair of U.V.-type DNA damage. Oncogene, 10, 1053-1059.
19. Wang, X.W., Yeh, H., Schaeffe, L., Roy, R., Moncollin, V., Egly, J.M., Wang, Z., Friedberg, E.C., Evans, M.K., Taffe, B.G., Bohr, V.A., Weeda, G., Hoeijmakers, J.H.J., Forrester, K. and Harris, C.C. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet., 10, 188-195.
20. Yagi, T., Tatsumi-Miyajima, J., Sato, M., Kraemer, K.H. and Takebe, H. (1991) Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmids propagated in cells for Japanese xeroderma pigmentosum patients in complementation groups A and F. Cancer Res., 51, 3177-3182.
21. Yamagishi, N., Miyakoshi, J. and Takebe, H. (1997) Decrease in the frequency of x-ray-induced mutation by wild-type p53 protein in human osteosarcoma cells. Carcinogenesis, 18, in press.
22. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C. and Wahl, G.M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948.
23. Ziegler, A., Jonason, A.S., Leffell, D.J., Simon, J.A., Kimmelman, J., Remington, L., Jacks, T. and Brash, D E. (1994) Sunburn and p53 in the onset of skin cancer. Nature, 372, 773-776.